Tempest Therapeutics Inc (TPST)
Insider transactions
A complete record of Form 4 filings tracking every share acquisition and disposal by executives, directors, and senior officers. Filterable by date range and transaction type, the table exposes the direct market actions of those with the deepest knowledge of a company's operations — providing a factual, data-driven signal of internal conviction that complements traditional fundamental and technical analysis.
Transaction date | Executive | Executive Title | Security Type | Acquisition / Disposal | Shares | Share price |
|---|---|---|---|---|---|---|
| Jun 4, 2026 | RICHEY, WILLIAM DRAKE | Director | Stock Option (right to buy) | Acquisition | 25,000 | 0 |
| Jun 4, 2026 | YEE, JOHN D. | Director | Stock Option (right to buy) | Acquisition | 25,000 | 0 |
| Mar 31, 2026 | MAESTAS, NICHOLAS | Chief Financial Officer | Employee Stock Option (right to buy) | Acquisition | 140,000 | 0 |
| Mar 31, 2026 | TROJANOWSKI, JUSTIN | Corporate Controller | Employee Stock Option (right to buy) | Acquisition | 22,000 | 0 |
| Mar 24, 2026 | ANGEL, MATTHEW | Director, CEO and President, 10% Owner | Common Stock | Acquisition | 231,482 | 2.16 |
| Mar 24, 2026 | ANGEL, MATTHEW | Director, CEO and President, 10% Owner | Series B Warrant (right to buy) | Acquisition | 231,482 | |
| Mar 24, 2026 | ANGEL, MATTHEW | Director, CEO and President, 10% Owner | Series A Warrant (right to buy) | Acquisition | 231,482 | |
| Feb 4, 2026 | ANGEL, MATTHEW | Director, CEO and President, 10% Owner | Employee Stock Option (right to buy) | Acquisition | 269,621 | 0 |
| Jan 27, 2026 | RAAB, MICHAEL | Director | Stock Option (right to buy) | Acquisition | 1,230 | 0 |
| Jan 27, 2026 | PELLIZZARI, CHRISTINE A | Director | Stock Option (right to buy) | Acquisition | 1,230 | 0 |
| Jan 27, 2026 | NICHOL, GEOFFREY | Director | Stock Option (right to buy) | Acquisition | 1,230 | 0 |
| Jan 27, 2026 | SIMANTOV, RONIT | Director | Stock Option (right to buy) | Acquisition | 1,230 | 0 |